Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
5.28 EUR | -0.19% |
|
-10.02% | +20.93% |
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 58 | 13.09.10 | |
Jinchul Jeong
DFI | Director of Finance/CFO | - | - |
Michael Smith
CMP | Compliance Officer | - | - |
Brent Gardner
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jebediah Ledell
COO | Chief Operating Officer | 49 | 01.12.21 |
Stefanie Solomon
CMP | Compliance Officer | - | - |
Anisha Wharton
LAW | General Counsel | - | 01.01.21 |
Danielle Holland
LAW | General Counsel | - | - |
David Crist
SAM | Sales & Marketing | - | 19.10.20 |
Corporate Officer/Principal | - | 01.12.17 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 58 | 13.09.10 | |
Jaywin Lee
BRD | Director/Board Member | - | 19.01.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 34 763 127 | 34 693 418 ( 99,80 %) | 0 | 99,80 % |
Unternehmenskontakt
AVEO Pharmaceuticals, Inc.
1 Marina Park Drive 12th floor
02210, Boston
+857 400 0101
http://www.aveooncology.com![Straße AVEO Pharmaceuticals, Inc.(VPA)](https://cdn.zonebourse.com/static/address/50916923.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+4.57% | 96.72 Mrd. | |
+5.66% | 41.43 Mrd. | |
-12.80% | 32.7 Mrd. | |
+80.99% | 29.06 Mrd. | |
-15.53% | 15.38 Mrd. | |
-8.70% | 12.97 Mrd. | |
-12.22% | 11.36 Mrd. | |
+183.25% | 9.9 Mrd. | |
+3.60% | 8.93 Mrd. |
- Börse
- Aktien
- A2P0CL Aktie
- A0YH9L Aktie
- Unternehmen AVEO Pharmaceuticals, Inc.